Shanghai Fosun Pharmaceutical gibt Termin für außerordentliche Hauptversammlung bekannt
I'm PortAI, I can summarize articles.
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. will hold an extraordinary general meeting on February 27, 2026, at the Sky Fortune Boutique Hotel in Shanghai. The agenda includes voting on the approval of the spin-off of its subsidiary Fosun Adgenvax for a listing on the Main Board of the Hong Kong Stock Exchange.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments